Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli

被引:73
作者
Payot, S [1 ]
Avrain, L
Magras, C
Praud, K
Cloeckaert, A
Chaslus-Dancla, E
机构
[1] INRA, UR086 BioAgresseurs, F-37380 Nouzilly, France
[2] Unite Mycoplasmol Bacteriol, Agence Francaise Secur Sanitarire Aliments, F-22440 Ploufragan, France
[3] Ecole Natl Vet SECALIM, Unite Mixte Rech, INRA, F-44307 Nantes, France
关键词
Campylobacter; fluoroquinolone; erythromycin; mutation; efflux; inhibitor;
D O I
10.1016/j.ijantimicag.2003.12.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Thirty-eight avian and swine French isolates of Campylobacter coli were studied for their mechanisms of co-resistance to fluoroquinolones and erythromycin. A Thr86Ile modification of GyrA, responsible for fluoroquinolone resistance, was found in all the strains. Two different levels of resistance to erythromycin (MIC of 8-16 or greater than or equal to256 mg/l) were observed. A A2075G mutation in the 23S rRNA genes was found only in the highly-resistant strains. Phe-Arg-beta-naphthylamide, an efflux pump inhibitor, potentiated erythromycin in all the strains examined but restored susceptibility only in the strains with a low-level of resistance. This suggests the involvement of efflux in intrinsic and in acquired low-level of resistance to erythromycin in C. coli. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 30 条
[1]  
Avrain L., 2001, British Poultry Science, V42, pS32
[2]   Single or double mutational alterations of GyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli [J].
Bachoual, R ;
Ouabdesselam, S ;
Mory, F ;
Lascols, C ;
Soussy, CJ ;
Tankovic, J .
MICROBIAL DRUG RESISTANCE, 2001, 7 (03) :257-261
[3]   The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204 [J].
Baucheron, S ;
Imberechts, H ;
Chaslus-Dancla, E ;
Cloeckaert, A .
MICROBIAL DRUG RESISTANCE, 2002, 8 (04) :281-289
[4]   2003 report by the members of the French Society of Microbiology Antiobiogram Committee [J].
Carret, G ;
Cavallo, JD ;
Chardon, H ;
Chidiac, C ;
Choutet, P ;
Courvalin, P ;
Dabernat, H ;
Drugeon, H ;
Dubreuil, L ;
Goldstein, F ;
Jarlier, V ;
Leclercq, R ;
Nicholas-Chanoine, MH ;
Philippon, A ;
Quentin-Noury, C ;
Rouveix, B ;
Sirot, J ;
Soussy, CJ .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (04) :364-391
[5]   Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains [J].
Cooper, R ;
Segal, H ;
Lastovica, AJ ;
Elisha, BG .
JOURNAL OF APPLIED MICROBIOLOGY, 2002, 93 (02) :241-249
[6]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+
[7]   Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolates from broiler chickens isolated at an Irish poultry processing plant [J].
Fallon, R ;
O'Sullivan, N ;
Maher, M ;
Carroll, C .
LETTERS IN APPLIED MICROBIOLOGY, 2003, 36 (05) :277-281
[8]  
Friedman C.R., 2000, CAMPYLOBACTER, V2nd, P121
[9]  
Jacobs-Reitsma W., 2000, CAMPYLOBACTER, V2nd, P467
[10]   Macrolide resistance in Campylobacter coli of animal origin in Denmark [J].
Jensen, LB ;
Aarestrup, FM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :371-372